BlackRock’s Chembio diagnostics, Inc. CEMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-206,051
| Closed | -$91.1K | – | 5730 |
|
|
2023
Q1 | $91.1K | Sell |
206,051
-193
| -0.1% | -$76 | ﹤0.01% | 4978 |
|
|
2022
Q4 | $45.3K | Sell |
206,244
-185
| -0.1% | -$55 | ﹤0.01% | 5251 |
|
|
2022
Q3 | $74K | Sell |
206,429
-287
| -0.1% | -$196 | ﹤0.01% | 5268 |
|
|
2022
Q2 | $134K | Sell |
206,716
-75,822
| -27% | -$50.4K | ﹤0.01% | 5149 |
|
|
2022
Q1 | $231K | Buy |
282,538
+4,661
| +2% | +$4.35K | ﹤0.01% | 5073 |
|
|
2021
Q4 | $316K | Buy |
277,877
+10,669
| +4% | +$21.7K | ﹤0.01% | 4999 |
|
|
2021
Q3 | $668K | Buy |
267,208
+67,959
| +34% | +$189K | ﹤0.01% | 4673 |
|
|
2021
Q2 | $593K | Sell |
199,249
-1,064,626
| -84% | -$3.71M | ﹤0.01% | 4654 |
|
|
2021
Q1 | $4.44M | Buy |
1,263,875
+64,281
| +5% | +$358K | ﹤0.01% | 3994 |
|
|
2020
Q4 | $5.7M | Buy |
1,199,594
+30,110
| +3% | +$156K | ﹤0.01% | 3644 |
|
|
2020
Q3 | $5.68M | Buy |
1,169,484
+25,962
| +2% | +$123K | ﹤0.01% | 3512 |
|
|
2020
Q2 | $3.72M | Buy |
1,143,522
+930,864
| +438% | +$8.84M | ﹤0.01% | 3639 |
|
|
2020
Q1 | $1.09M | Sell |
212,658
-785
| -0.4% | -$3.18K | ﹤0.01% | 3844 |
|
|
2019
Q4 | $974K | Buy |
213,443
+24,711
| +13% | +$120K | ﹤0.01% | 4001 |
|
|
2019
Q3 | $1.16M | Sell |
188,732
-2,106
| -1% | -$12.6K | ﹤0.01% | 3931 |
|
|
2019
Q2 | $1.16M | Buy |
190,838
+141,742
| +289% | +$956K | ﹤0.01% | 3962 |
|
|
2019
Q1 | $272K | Sell |
49,096
-1,186
| -2% | -$7.71K | ﹤0.01% | 4198 |
|
|
2018
Q4 | $285K | Buy |
50,282
+4,083
| +9% | +$30.1K | ﹤0.01% | 4165 |
|
|
2018
Q3 | $485K | Buy |
46,199
+1,967
| +4% | +$21.1K | ﹤0.01% | 4146 |
|
|
2018
Q2 | $491K | Buy |
44,232
+10,120
| +30% | +$91K | ﹤0.01% | 4105 |
|
|
2018
Q1 | $273K | Sell |
34,112
-597
| -2% | -$4.77K | ﹤0.01% | 4147 |
|
|
2017
Q4 | $284K | Buy |
34,709
+1,460
| +4% | +$9.89K | ﹤0.01% | 4139 |
|
|
2017
Q3 | $207K | Sell |
33,249
-1,284
| -4% | -$7.9K | ﹤0.01% | 4218 |
|
|
2017
Q2 | $209K | Sell |
34,533
-60
| -0.2% | -$375 | ﹤0.01% | 4234 |
|
|
2017
Q1 | $184K | Buy |
+34,593
| New | +$201K | ﹤0.01% | 4235 |
|
Other funds holding CEMI
BlackRock's CEMI Position: Q2 2023 in Review
BlackRock sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2023, closing a stake of 206,051 shares — an estimated $91.1K sold.
BlackRock first reported a position in CEMI in Q1 2017 and held it in 25 quarters. The position peaked at $5.7M in Q4 2020. 1 fund tracked by Wall St. Rank holds CEMI as of Q2 2023.
- BlackRock reported no remaining Chembio diagnostics, Inc. position as of Q2 2023 after selling out during the quarter.
- BlackRock sold 206,051 Chembio diagnostics, Inc. shares in Q2 2023, an estimated $91.1K.
- BlackRock first reported a position in Chembio diagnostics, Inc. in Q1 2017 and held it in 25 quarters.
- BlackRock's Chembio diagnostics, Inc. position peaked at $5.7M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2023.
Based on BlackRock's 13F filing for Q2 2023, filed 11 Aug 2023.